Weizmann Institute of Science
Weizmann Institute of Science is a private nonprofit multidisciplinary research institution in Rehovot, Israel, conducting fundamental research across natural and exact sciences. It trains 1,700 graduate students and postdocs, employs 191 faculty across 286 research groups, and commercializes discoveries through its technology transfer arm Yeda and pre-applied unit Bina.
- Company typePrivate
- Founded1934
- HeadquartersRehovot, Israel
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
What Weizmann Institute of Science does
Weizmann Institute of Science is a private, nonprofit multidisciplinary research institution headquartered in Rehovot, Israel, founded in 1934 as the Daniel Sieff Research Institute and renamed in 1949 after Chaim Weizmann, Israel's first president and a chemist. The institute operates 286 research groups across biochemistry, biology, chemistry, physics, mathematics, computer science, and science education, employing approximately 2,600 staff including 191 faculty scientists and supporting 1,700 graduate students and postdoctoral fellows. Its research portfolio spans quantum photonics, AI-driven personalized medicine, biosignature detection for astrobiology, and metabolic engineering, with notable outputs including a 40-fold increase in psychedelic compound biosynthesis via engineered plant pathways and single-atom trapping on photonic chips with approximately 30% loading probability.
The institute's commercial and translational outputs flow through two wholly-owned units: Yeda Research and Development Co. Ltd., which holds exclusive rights to commercialize IP developed by institute scientists through licensing, royalties, and spin-off equity; and Bina, a pre-applied research unit established in 2021 under the Vice President for Innovation to bridge basic research toward commercial application. Spin-offs include Quantum Art (trapped-ion quantum computing, spun out 2022, $100M Series A in 2025). Named licensing and collaboration partners include Cedars-Sinai Medical Center (US healthcare), Actithera (radiopharmaceuticals), Phytolon (food biotech), Quantum X Labs, and Quantum Source.
The business model combines government research funding (Israeli government, European Research Council), licensing and royalty revenue from Yeda, tuition and program fees from graduate and postdoctoral education, and philanthropic contributions. As a private nonprofit, Weizmann does not publicly disclose revenue; it produces open scientific publications rather than commercial products, with value captured downstream through IP licensing, spin-off equity, and trained scientific talent.
Weizmann Institute of Science firmographics
Firmographics- Name
- Weizmann Institute of Science
- Legal name
- Weizmann Institute of Science
- Website
- https://weizmann.ac.il
- Company type
- Private
- Founded year
- 1934
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Weizmann Institute of Science is a private nonprofit multidisciplinary research institution in Rehovot, Israel, conducting fundamental research across natural and exact sciences. It trains 1,700 graduate students and postdocs, employs 191 faculty across 286 research groups, and commercializes discoveries through its technology transfer arm Yeda and pre-applied unit Bina.
- Ownership category
- akta.pro rank
Weizmann Institute of Science industry classification
Industry- Product category
- Higher Education and Scientific Research
- NAICS
- Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Patent Owners & Lessors (6794), Books: Publishing Or Publishing & Printing (2731)
- akta.pro primary industry
- Comprehensive Doctoral Research Universities (Multi-Disciplinary) (EDAHABAA)
- akta.pro secondary industries
- STEM-Focused Research Universities (Engineering & Applied Sciences) (EDAHABAB), Life Sciences (Biology, Ecology, Agriculture) Scholarly Publishing (EDAGAFAC), Scientific & Laboratory Reference (Chemistry, Biology, Physics; Methods & Protocols) (EDAGAGAG), Research Administration & Compliance (Sponsored Programs, IRB/REB) (EDADAKAH)
Keywords
Where Weizmann Institute of Science is headquartered
LocationHeadquarters
- HQ city
- Rehovot
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Weizmann Institute of Science business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Others
Revenue model
- Government Research Funding: Primary funding from Israeli government sources and international research grants including European Research Council (ERC) grants. The institute receives institutional support for fundamental research activities.
- Technology Transfer through Yeda: Yeda Research and Development Co. is the commercial arm of the institute with exclusive rights to commercialize intellectual property developed by institute scientists. Revenue generated through licensing agreements, patent royalties, and spin-off company equity.
- Educational Programs: Revenue from graduate education programs, visiting scholar programs, summer schools, and science education programs including the Kupcinet-Getz International Summer School and Bessie Lawrence International Summer Science Institute.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Weizmann Institute of Science product offering
Product offeringCore offering
The Weizmann Institute of Science is a multidisciplinary basic research institution that conducts fundamental scientific research across biochemistry, biology, chemistry, physics, mathematics, and computer science. It delivers outputs through open scientific publication, graduate and postdoctoral degree programs, and technology transfer via its wholly owned commercial arm Yeda Research and Development Co., which licenses intellectual property and supports spin-off companies.
Product overview
The Weizmann Institute of Science is a premier research institution that does not offer commercial products in the traditional sense. Its innovation ecosystem consists of technology transfer through Yeda Research and Development Company (its commercial arm), and Bina, a pre-application research unit that bridges basic research to commercial activity. The institute's research spans multiple faculties including biochemistry, biology, chemistry, mathematics, computer science, and physics, with specialized centers for personalized medicine, cancer research, and quantum science.
Differentiator
Problem solved
Functional benefit
Products and services
- Yeda Research and Development Co. Technology Transfer and Licensing Wholly owned commercial arm that holds exclusive rights to commercialize intellectual property developed by Weizmann Institute scientists. Generates revenue through licensing agreements, patent royalties, and spin-off company equity for biotech, pharma, and technology companies.
- Bina Pre-Applied Research Unit Scientific unit established in 2021 under the Vice President for Innovation that supports basic research and bridges it to commercial activity, helping develop initial applied-research ideas from researchers across all basic research domains at the institute.
- Graduate and Postdoctoral Education Programs Competitive MSc, PhD, and MD-PhD programs, plus postdoctoral fellowships, recruiting international students to conduct research under faculty scientists across biology, chemistry, physics, mathematics, and computer science. Includes the Kupcinet-Getz International Summer School and Bessie Lawrence International Summer Science Institute.
Quantifiable outcome
- Engineering plant metabolism to produce psychedelic compounds with 40-fold increase in production through single amino acid modification
- +2 more outcomes
Companies that use Weizmann Institute of Science
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Weizmann Institute of Science technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability6 records
Feature4 records
Weizmann Institute of Science partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered minor and core.
- Quantum X LabsminorProf. Oren Raz from Weizmann Institute appointed to Quantum X Labs Scientific Advisory Board. Prof. Raz specializes in non-equilibrium quantum thermodynamics with over 2,600 citations, supporting QXL's neutral-atom quantum computing platform development.
- Quantum SourceminorCollaborative research with Quantum Source on trapping single atoms on photonic chips for integrated quantum optics. Demonstrated measurable atom-photon coupling as building block for chip-integrated quantum photonic systems.
- Cedars-Sinai Medical CentercoreExpanding clinical, scientific, and educational partnerships spanning cardiovascular medicine, digital health and AI-driven solutions, inflammatory bowel disease treatment programs, and stem cell research at the International Space Station. A delegation of Cedars-Sinai physicians visited Israeli hospitals to explore training opportunities.
- Evogene, Systasy Bioscience, LMU University Hospital MunichminorInternational collaboration backed by EUREKA grant for AI-driven drug discovery targeting neutrophil-derived inflammatory diseases. Weizmann Institute contributes computational design integration and experimental validation.
- British Embassy in Israel and UK Research InstitutionsminorUK-Israel genomics collaboration involving a delegation of ten Israeli genomics experts visiting UK's Knowledge Quarter, Francis Crick Institute, and University College London to strengthen bilateral collaboration in life sciences innovation.
- ActitheracoreActithera secured exclusive license from Yeda (Weizmann's commercial arm) to two patent families for covalent chemistry technologies developed by Professor Nir London for targeted radiopharmaceutical therapies. The technologies aim to improve tumor selectivity and retention in cancer treatments.
Scale indicators4 records
Recent moves7 records
Expansion highlights5 records
Weizmann Institute of Science competitors and assessment
Company assessmentDirect peers
- Technion – Israel Institute of Technology: Israel's other leading STEM-focused research university, also based in Israel with comparable faculty scale, graduate programs, and technology transfer activity. Both institutions compete for Israeli government R&D funding and produce spin-offs from fundamental research.
- Hebrew University of Jerusalem: Israel's premier comprehensive research university with Yissum technology transfer arm, directly comparable to Weizmann's Yeda. Both compete for talent, grants, and commercial partnerships within Israel's research ecosystem.
- Max Planck Society: Germany's leading basic research organization with a similar model of institute-based fundamental research, large faculty/student populations, and Max Planck Innovation as technology transfer arm. Operates on government and grant funding with comparable global reputation.
- Broad Institute of MIT and Harvard: Joint MIT-Harvard biomedical and genomic research institute operating with a similar model of collaborative research groups, large-scale datasets (analogous to Human Phenotype Project), and industry partnerships in life sciences.
- Pasteur Institute: Leading European life sciences research institution with similar multidisciplinary research groups, large graduate/postdoc population, and active industry spin-off activity. Compares closely on fundamental biology and chemistry research output.
- Francis Crick Institute: UK's flagship biomedical discovery institute with ~1,500 scientists, similar research-group-based structure, and strong partnerships with UK universities and hospitals. Operates as a recent UK-Israel genomics partner, making it directly comparable in mission and scale.
Broad incumbents
- Massachusetts Institute of Technology (MIT): Global leader in STEM research and education with much larger scale and broader commercialization engine (via TLO). Competes with Weizmann for top faculty, ERC/NIH grants, and industrial partnerships across similar disciplines.
- California Institute of Technology (Caltech): Elite small-scale research university focused on physical sciences, engineering, and biology with strong NASA/JPL ties. Directly comparable in research output per capita and operates similar multidisciplinary faculty group structure.
- ETH Zurich: Europe's leading STEM research university with comparable multidisciplinary research scope, large international student body, and active technology transfer. Competes directly for ERC funding and European research talent.
- Howard Hughes Medical Institute (HHMI): Major US biomedical research organization with analogous investigator-based research model, substantial funding capacity, and Janelia Research Campus for multidisciplinary fundamental science. Comparable in research output and faculty-driven discovery model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Weizmann Institute of Science social profiles
Digital presenceWeizmann Institute of Science compliance and trust
Trust signalCompliance1 record
Weizmann Institute of Science financial estimates
Financial estimateRevenue estimate
Valuation estimate
Weizmann Institute of Science leadership team
Management profileNumber of profiles
Profiles4 records
Weizmann Institute of Science subsidiaries and ownership
Company hierarchySubsidiaries2 records
Weizmann Institute of Science funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Weizmann Institute of Science M&A and investment
M&A and investmentM&A
Investments3 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Weizmann Institute of Science
What does Weizmann Institute of Science do?
The Weizmann Institute of Science is a multidisciplinary basic research institution that conducts fundamental scientific research across biochemistry, biology, chemistry, physics, mathematics, and computer science. It delivers outputs through open scientific publication, graduate and postdoctoral degree programs, and technology transfer via its wholly owned commercial arm Yeda Research and Development Co., which licenses intellectual property and supports spin-off companies.
Is Weizmann Institute of Science a public or private company?
Weizmann Institute of Science is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Weizmann Institute of Science founded?
Weizmann Institute of Science was founded in 1934. It employs 1,001 to 5,000 people.
Where is Weizmann Institute of Science based?
Weizmann Institute of Science is headquartered in Rehovot, Israel, in the Middle East region.
How does Weizmann Institute of Science make money?
Three revenue lines are on record. Government Research Funding is the primary driver. The others are technology Transfer through Yeda and educational Programs.
Who are Weizmann Institute of Science's main competitors?
Direct peers on record are Technion – Israel Institute of Technology, Hebrew University of Jerusalem, Max Planck Society, Broad Institute of MIT and Harvard, Pasteur Institute and Francis Crick Institute. Broad incumbents are Massachusetts Institute of Technology (MIT), California Institute of Technology (Caltech), ETH Zurich and Howard Hughes Medical Institute (HHMI).
Does Weizmann Institute of Science have an API?
No public API is recorded for Weizmann Institute of Science.
What industry is Weizmann Institute of Science in?
Weizmann Institute of Science's product category is Higher Education and Scientific Research. Its primary akta.pro industry code is EDAHABAA, Comprehensive Doctoral Research Universities (Multi-Disciplinary), with a secondary code of EDAHABAB, STEM-Focused Research Universities (Engineering & Applied Sciences). Its NAICS code is 5417 and its SIC code is 8731.